Genetic analysis and prenatal diagnosis for patients with non-syndromic hearing impairment
10.11958/20170758
- VernacularTitle:208例非综合征性耳聋患者的基因诊断与产前诊断
- Author:
Yuehong LIANG
;
Chenchun REN
;
Wenjing WANG
;
Haixia ZHANG
;
Weiwei YANG
;
Deming LI
;
Yuexiang ZHANG
- Keywords:
deafness;
prenatal diagnosis;
non-syndromic hearing impairment;
GJB2 gene;
SLC26A4 gene;
sequencing;
gene chip
- From:
Tianjin Medical Journal
2017;45(9):953-957
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the genetic pathogen of patients with non-syndromic hearing impairment and to provide prenatal diagnosis for the families of hereditary deafness. Methods Mutation screening of GJB2, SLC26A4, GJB3 and mitochondrial 12 S rRNA genes was performed in 208 patients with non-syndromic hearing impairment by gene chip. Then direct sequencing was used in 41 patients who were found one mutation of GJB2 or SLC26A4 gene. And prenatal diagnosis was carried out in two families by direct sequencing. Results Eighty-six patients (41.35％) were found at least one mutation by gene chip. Among them, 40 patients were found to carry two mutations and 46 patients were found to carry one mutation. The most frequent mutation was 235delC, which was found in 46 patients. And 12 cases were found the second mutation through direct sequencing. A total of 52 (25.00％) patients were detected two mutations. Prenatal diagnosis showed that one fetus carried compound mutations of 299-300delAT and 235delC, and another one carried heterozygous mutation of IVS7-2A>G. Conclusion Patients with non-syndromic hearing impairment can be accurately diagnosed by gene chip and Sanger sequencing. The prenatal diagnosis is primary means for high-risk fetuses.
